In patients with migraine, erenumab was safe and tolerable and effectively reversed migraine deterioration during treatment pauses.

The WHO reports that TB cases hit a record high in 2023, with more than 8 million diagnoses and 1.25 million deaths, meaning it is once again the leading cause of death from infectious disease after ...

For children with SARS-CoV-2 infection, elevated BMI is associated with an increased risk of postacute sequelae of SARS-CoV-2 infection.

The approved of Vistaseal has been expanded to include use in pediatric patients as an adjunct to hemostasis for mild to moderate bleeding.

Influenza-associated hospitalization rates vary across seasons, and only returned to recent pre-COVID-19 pandemic levels in the 2022-2023 influenza season.

Injected micronized amnion/chorion bilayer product significantly reduces time to symptom relief in patients with refractory interstitial cystitis/bladder pain syndrome.

Although the future of AI in health care is somewhat predictable, its current application suggests the delivery of patient care may be revolutionized.

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Injectable biologics may provide superior analgesia, functionality, and QOL vs conventional approaches to chronic pain, ...

Clinicians fail to rescue women with complications after high-risk vascular and cardiac surgeries more often than men.

Persistent postoperative opioid use and chronic postsurgical pain had different risk profiles, indicating they are distinct entities.

For older patients with breast cancer, non-Hispanic Black race is associated with increased odds of not receiving GCC and less timely initiation of treatment.